| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1051/MEDSCI/2011276014 |
| P9108 | Erudit article ID | 2011276014 |
| P698 | PubMed publication ID | 21718646 |
| P5875 | ResearchGate publication ID | 51457143 |
| P50 | author | Nathalie Grandvaux | Q85655989 |
| P2860 | cites work | IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases | Q22010432 |
| IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex | Q22254561 | ||
| NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation | Q28141521 | ||
| IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway | Q28190704 | ||
| Triggering the interferon antiviral response through an IKK-related pathway | Q28191761 | ||
| IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2 | Q28198356 | ||
| IKKi/IKKϵ Plays a Key Role in Integrating Signals Induced by Pro-inflammatory Stimuli | Q28203011 | ||
| Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity | Q28290992 | ||
| Shared principles in NF-kappaB signaling | Q29547234 | ||
| Integrative genomic approaches identify IKBKE as a breast cancer oncogene | Q33287979 | ||
| Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation | Q33456429 | ||
| IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer | Q33662031 | ||
| Estrogen receptor mutations and changes in downstream gene expression and signaling | Q34112728 | ||
| Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors | Q35169909 | ||
| The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy | Q36010801 | ||
| The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection | Q36402648 | ||
| Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection | Q36402672 | ||
| Advances in targeting IKK and IKK-related kinases for cancer therapy | Q37036746 | ||
| Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer | Q37257188 | ||
| The IKK-related kinases: from innate immunity to oncogenesis | Q37374645 | ||
| Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer | Q37376029 | ||
| CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes | Q37448141 | ||
| Genomic structure and functional characterization of the promoter region of human IkappaB kinase-related kinase IKKi/IKKvarepsilon gene. | Q38325357 | ||
| Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. | Q39628016 | ||
| Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint | Q39826073 | ||
| Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation | Q39869345 | ||
| Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon | Q40247827 | ||
| IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation | Q40255884 | ||
| Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers | Q42458122 | ||
| Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells | Q46853168 | ||
| Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. | Q46890324 | ||
| [CYLD deubiquitinase as a recurrent target in oncogenic processes]. | Q53285080 | ||
| [The alternative NF-kB activation pathway and cancer: friend or foe?]. | Q53426911 | ||
| P433 | issue | 6-7 | |
| P407 | language of work or name | French | Q150 |
| P304 | page(s) | 619-625 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | médecine/sciences | Q3332441 |
| P1476 | title | The IKKε kinase in breast cancer: from oncogenesis to treatment resistance | |
| P478 | volume | 27 |
| Q33717414 | Detection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis. |
| Q35940908 | Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling |
| Q53285080 | [CYLD deubiquitinase as a recurrent target in oncogenic processes]. |
Search more.